FIGURE 1.
Schematic illustration of engineered bacteria that generate therapeutic agents for inflammatory bowel disease. Engineered bacteria generate therapeutic agents to treat IBD through immunomodulation, antioxidative stress, barrier restoration, and microbial regulation in the intestine.